CD200R1 antibody (FITC)

Catalog No. ABIN2661578

Product Details anti-CD200R1 Antibody (FITC)

Target: CD200R1 (CD200 Receptor 1 (CD200R1))

Reactivity: Mouse

Host: Rat

Clonality: Monoclonal

Conjugate: This CD200R1 antibody is conjugated to FITC

Application: Intracellular Flow Cytometry (ICFC)

Purification: The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions. The solution is free of unconjugated FITC.

Clone: OX-110

Isotype: IgG2a kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Concentration: 0.5 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from prolonged exposure to light. Do not freeze.

Storage: 4 °C

Storage Comment: The antibody solution should be stored undiluted between 2°C and 8°C.

Target Details for CD200R1

Target: CD200R1 (CD200 Receptor 1 (CD200R1))

Alternative Name: CD200R (CD200R1 Products)

Synonyms: CD200R antibody, HCRTR2 antibody, MOX2R antibody, OX2R antibody, Mox2r antibody, CD200R1 antibody, CD200R2 antibody, CD200R-B1V1 antibody, CD200R1A antibody, CD200 receptor 1 antibody, cell surface glycoprotein CD200 receptor 1 antibody, CD200 receptor 1-like antibody, CD200R1 antibody, Cd200r1 antibody, LOC487977 antibody, CD200R1L antibody

Background: CD200R, also known as OX2R, is a membrane glycoprotein with up to 70 % of its weight derived from N-linked glycosylation. CD200R is expressed primarily by monocytes and neutrophils but also by other leukocytes including T lymphocytes and mast cells. The interaction between CD200 and CD200R may contribute to pathways that suppress and limit macrophage induced inflammatory damage in tissue. Studies suggest that CD200-CD200R interaction may be involved in the control of myeloid cellular function. Levels of expression on resting peripheral blood cells are relatively low.